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We report on the epidemiology of HTLV in England and
Wales (E&W) over the past decade. HTLV diagnoses in
E&W are reported to PHE by clinicians, laboratories and
NHS Blood and Transplant. Confirmatory testing is done
by the VRD. Reports received up to the end of January
2013 were included in these analyses. Of the 892 persons
diagnosed with HTLV in E&W between 2003-2012, the
majority had HTLV-1 (88%; 721/818). Two-thirds were
women (64%; 573/889) and 87% were aged ≥35 years
(768/887). Where ethnicity was reported (568), black
Caribbeans accounted for 59% (337) of diagnoses, fol-
lowed by whites (21%; 117), black Africans (11%; 66) and
persons of Indian-subcontinent ethnicity (3%; 18). 43%
(142/338) of people diagnosed probably acquired HTLV
infection in the UK and 40% (135/338) in Latin America/
Caribbean. The majority of diagnoses were made among
those exposed through mother-to-child transmission
and/or heterosexual contact (90%; 381/423). For persons
presenting with HTLV-related symptoms (559), the med-
ian age was 57 years and 45 years for those without
symptoms (331). Median age for persons reported with
adult T cell lymphoma (117) was 59 years and 55 years
for HTLV-I-associated myelopathy (74). Of 283 sympto-
matic infections, 87% (247) were among black African/
Caribbeans. 75 (8.4%) persons died over the decade, 84%
(63) within one year of HTLV diagnosis. Though rare in
E&W, HTLV infection is life-long and can result in debil-
itating disease. Enhanced surveillance remains of public
health importance to continue building an epidemiologi-
cal picture of HTLV and to better understand clinical
disease progression.
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